DFW Capital Partners Makes Strategic Investment in WorldCare Clinical

WorldCare Clinical Acquires Digital Angiography Reading Center (DARC)

September 3, 2021

Healthcare Services

WorldCare Clinical, a portfolio company of DFW Capital Partners, has acquired New York-based Digital Angiography Reading Center (DARC), a leading ophthalmology imaging core lab. The add-on expands WorldCare Clinical's retinal and ophthalmic imaging capabilities and leverages WCC's global imaging CRO platform to support sponsors in clinical trials worldwide.

Kohlberg Acquires Majority Stake in Worldwide Clinical Trials

August 7, 2023

Healthcare Services

An affiliate of Kohlberg & Company agreed to acquire a majority stake in Worldwide Clinical Trials, a global contract research organization (CRO) headquartered in Research Triangle Park, North Carolina. The transaction is a recapitalization in which prior investor TJC, L.P. retains a meaningful minority equity stake; terms were not disclosed. Kohlberg will partner with Worldwide's management (Matt Jennings to become chairman) to support continued growth of the company's clinical trial and bioanalytical capabilities.

DW Healthcare Partners Invests in CareXM

November 16, 2020

Healthcare Services

DW Healthcare Partners, a healthcare-focused private equity firm, announced an investment in CareXM, a provider of virtual care and patient engagement solutions used by home health, hospice, physician practices and hospitals. The capital will support CareXM's continued product development and expansion of its 24/7 HIPAA-compliant virtual care and clinical nurse triage services across the United States.

Walter Capital Partners Makes Minority Growth Investment in MEDFAR Clinical Solutions

February 16, 2021

Healthcare Services

Walter Capital Partners led a group of investors in a minority growth investment of close to $25 million in MEDFAR Clinical Solutions to support the EMR provider's expansion in Canada and the U.S. MEDFAR is a Montreal-based cloud-based SaaS EMR/Care Management Solution (MYLE) and will leverage the capital and Walter Capital's operational expertise to accelerate market growth.

Edgewater Capital Partners Invests in CBCC Global Research

May 27, 2025

Healthcare Services

Edgewater Capital Partners, a Cleveland-based private equity firm, has partnered with the shareholders and management of CBCC Global Research, a Bakersfield-headquartered clinical contract research organization (CRO). Edgewater's investment will support CBCC's growth by funding people, technology, and infrastructure to expand its clinical trial services across oncology, CNS, ophthalmology and other therapeutic areas.

Worldwide Clinical Trials Acquires Catalyst Clinical Research

February 17, 2026

Healthcare Services

Worldwide Clinical Trials, a Kohlberg-backed contract research organization, has completed its acquisition of Nottingham-based oncology specialist Catalyst Clinical Research from QHP Capital. The deal expands Worldwide's early-phase oncology, biometrics, and functional service provider (FSP) capabilities, creating a combined organization of roughly 4,400 employees across more than 70 countries; financial terms were not disclosed.